| Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial E Ambrogini, F Cetani, L Cianferotti, E Vignali, C Banti, G Viccica, A Oppo, ... The Journal of Clinical Endocrinology & Metabolism 92 (8), 3114-3121, 2007 | 423 | 2007 |
| The estrogen receptor-α in osteoclasts mediates the protective effects of estrogens on cancellous but not cortical bone M Martin-Millan, M Almeida, E Ambrogini, L Han, H Zhao, RS Weinstein, ... Molecular endocrinology 24 (2), 323-334, 2010 | 341 | 2010 |
| FoxO-mediated defense against oxidative stress in osteoblasts is indispensable for skeletal homeostasis in mice E Ambrogini, M Almeida, M Martin-Millan, JH Paik, RA DePinho, L Han, ... Cell metabolism 11 (2), 136-146, 2010 | 302 | 2010 |
| Glucocorticoids and tumor necrosis factor α increase oxidative stress and suppress Wnt protein signaling in osteoblasts M Almeida, L Han, E Ambrogini, RS Weinstein, SC Manolagas Journal of Biological Chemistry 286 (52), 44326-44335, 2011 | 291 | 2011 |
| Estrogen receptor-α signaling in osteoblast progenitors stimulates cortical bone accrual M Almeida, S Iyer, M Martin-Millan, SM Bartell, L Han, E Ambrogini, ... The Journal of clinical investigation 123 (1), 2012 | 290 | 2012 |
| Genetic Analyses of the HRPT2 Gene in Primary Hyperparathyroidism: Germline and Somatic Mutations in Familial and Sporadic Parathyroid Tumors F Cetani, E Pardi, S Borsari, P Viacava, G Dipollina, L Cianferotti, ... The Journal of Clinical Endocrinology & Metabolism 89 (11), 5583-5591, 2004 | 277 | 2004 |
| Increased lipid oxidation causes oxidative stress, increased peroxisome proliferator-activated receptor-γ expression, and diminished pro-osteogenic Wnt signaling in the skeleton M Almeida, E Ambrogini, L Han, SC Manolagas, RL Jilka Journal of Biological Chemistry 284 (40), 27438-27448, 2009 | 273 | 2009 |
| FoxO proteins restrain osteoclastogenesis and bone resorption by attenuating H2O2 accumulation SM Bartell, HN Kim, E Ambrogini, L Han, S Iyer, S Serra Ucer, ... Nature communications 5 (1), 3773, 2014 | 242 | 2014 |
| FOXOs attenuate bone formation by suppressing Wnt signaling S Iyer, E Ambrogini, SM Bartell, L Han, PK Roberson, R de Cabo, RL Jilka, ... The Journal of clinical investigation 123 (8), 3409-3419, 2013 | 230 | 2013 |
| Morphometric vertebral fractures in postmenopausal women with primary hyperparathyroidism E Vignali, G Viccica, D Diacinti, F Cetani, L Cianferotti, E Ambrogini, ... The Journal of Clinical Endocrinology & Metabolism 94 (7), 2306-2312, 2009 | 209 | 2009 |
| Oxidative Stress Stimulates Apoptosis and Activates NF-κB in Osteoblastic Cells via a PKCβ/p66shc Signaling Cascade: Counter Regulation by Estrogens or … M Almeida, L Han, E Ambrogini, SM Bartell, SC Manolagas Molecular Endocrinology 24 (10), 2030-2037, 2010 | 187 | 2010 |
| Should parafibromin staining replace HRTP2 gene analysis as an additional tool for histologic diagnosis of parathyroid carcinoma? F Cetani, E Ambrogini, P Viacava, E Pardi, G Fanelli, AG Naccarato, ... European Journal of Endocrinology 156 (5), 547-554, 2007 | 159 | 2007 |
| A quick intraoperative parathyroid hormone assay in the surgical management of patients with primary hyperparathyroidism: a study of 206 consecutive cases E Vignali, A Picone, G Materazzi, S Steffè, P Berti, L Cianferotti, F Cetani, ... European journal of endocrinology 146 (6), 783-788, 2002 | 150 | 2002 |
| Estrogens attenuate oxidative stress and the differentiation and apoptosis of osteoblasts by DNA‐binding‐independent actions of the ERα M Almeida, M Martin‐Millan, E Ambrogini, R Bradsher III, L Han, XD Chen, ... Journal of Bone and Mineral Research 25 (4), 769-781, 2010 | 132 | 2010 |
| Decreased oxidative stress and greater bone anabolism in the aged, when compared to the young, murine skeleton with parathyroid hormone administration RL Jilka, M Almeida, E Ambrogini, L Han, PK Roberson, RS Weinstein, ... Aging cell 9 (5), 851-867, 2010 | 130 | 2010 |
| Genetic analyses in familial isolated hyperparathyroidism: implication for clinical assessment and surgical management F Cetani, E Pardi, E Ambrogini, M Lemmi, S Borsari, L Cianferotti, ... Clinical endocrinology 64 (2), 146-152, 2006 | 76 | 2006 |
| Autoimmune hepatitis during intravenous glucocorticoid pulse therapy for Graves’ ophthalmopathy treated successfully with glucocorticoids themselves M Marinò, E Morabito, MA Altea, E Ambrogini, F Oliveri, MR Brunetto, ... Journal of Endocrinological Investigation 28, 280-284, 2005 | 58 | 2005 |
| Oxidation-specific epitopes restrain bone formation E Ambrogini, X Que, S Wang, F Yamaguchi, RS Weinstein, S Tsimikas, ... Nature communications 9 (1), 2193, 2018 | 46 | 2018 |
| Different somatic alterations of the HRPT2 gene in a patient with recurrent sporadic primary hyperparathyroidism carrying an HRPT2 germline mutation F Cetani, E Pardi, E Ambrogini, P Viacava, S Borsari, M Lemmi, ... Endocrine-Related Cancer 14 (2), 493-499, 2007 | 43 | 2007 |
| Deletion of FoxO1, 3, and 4 in osteoblast progenitors attenuates the loss of cancellous bone mass in a mouse model of type 1 diabetes S Iyer, L Han, E Ambrogini, M Yavropoulou, J Fowlkes, SC Manolagas, ... Journal of Bone and Mineral Research 32 (1), 60-69, 2017 | 34 | 2017 |
Stavros ManolagasDistinguished Professor of Medicine, UAMSVerified email at uams.edu
